Seite wählen

Soon, a new cancer drug from Bayer

Pharmaceutical and chemical giant Bayer has a new cancer drug in the pipeline, for gastrointestinal tumours (Gist), which continue to grow in spite of standard therapy treatment. In the U.S., it is likely that the rubber-stamped approval will be sought immediately, as...